Cardio Diagnostics Insider Trades
NASDAQ: CDIOHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 0 · $0
- Shares bought / sold
- 0 / 0
- Net activity
- Net buying $0
Cardio Diagnostics insider activity
No Cardio Diagnostics insider transactions were reported in the last 12 months; the table shows the most recent historical filings. The most recent filing shows Dogan Timur (Chief Technology Officer) buying 68,965 shares at $0.29 on Sep 6, 2024. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put CDIO's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
CDIO insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Sep 6, 2024 | Dogan MeeshanthiniChief Technology Officer | Buy | 68,965 | $20.00K | Form 4 |
| Sep 6, 2024 | Philibert RobertChief Medical Officer | Buy | 7,460 | $2.12K | Form 4 |
| Sep 6, 2024 | Philibert RobertChief Medical Officer | Buy | 26,615 | $7.64K | Form 4 |
| Sep 6, 2024 | Dogan TimurChief Technology Officer | Buy | 68,965 | $20.00K | Form 4 |
| Sep 6, 2024 | Dogan MeeshanthiniChief Executive Officer | Buy | 68,965 | $20.00K | Form 4 |
| Sep 6, 2024 | Dogan MeeshanthiniChief Executive Officer | Buy | 68,965 | $20.00K | Form 4 |
| Sep 6, 2024 | Dogan TimurChief Technology Officer | Buy | 68,965 | $20.00K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4